First Header Logo Second Header Logo

Connection

Karen Haas to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Karen Haas has written about Drug Therapy, Combination.
Karen Haas
Connection Strength
0.166
Drug Therapy, Combination
  1. Dyevoich AM, Haas KM. Type I IFN, Ly6C+ cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination. Mol Cancer Ther. 2020 06; 19(6):1232-1242.
    View in: PubMed
    Score: 0.166
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.